Search by Title or ISSN:
ICI Journals Master List 2014
Annual Report ICI Journals Master List 2014
summarizing the 2014 year with full list of journals and publishers from database of Index Copernicus.
Index Copernicus Search Articles
to international indexing database ICI Journals Master List
in an international indexing database ICI Journals Master List
ICI Evaluation on Request
Order ICI Evaluation on Request and get to know with a detailed report of ICI Journal Master List evaluation.
prepared especially for your Journal and get to know how to improve it
ICI Publishers Panel
Get to know ICI Publishers Panel - a congeneric system for administering the editorial process in your Journal.
Do you want to use
on the cover or web page of your Journal? More information here
Show the ICV (Index Copernicus Value) to others and order a decorative Certificate - a proof of being indexed in ICI Journals Master List database.
The order form
About ICI Journals Master List
ICI Journals Master List 2014 -
Archives of Annual Report of
ICI Journals Master List
ICI Journals Master List 2014
IC Journals Master List 2013
IC Journals Master List 2012
IC Journals Master List 2011
IC Journals Master List 2010
IC Journals Master List 2009
IC Journals Master List 2008
IC Journals Master List 2007
IC Journals Master List 2006
IC Journals Master List 2005
International journal of ecosystems and ecology science (IJEES) [Int. j. ecosyst. ecol. sci.]
Int. j. ecosyst. ecol. sci., Volume 2017; 7(1): 179–186
Juliana Gjerazi1, Eritjan Tashi2, Ervis Rapaj1, Irma Tashi3, Regina Hasa2, Teuta Feleqi1, Jul Bushati2, Perlat Kapisyzi2
1District Hospital, Fier, Albania; 2University Hospital ‘Shefqet Ndroqi, Tirana, Albania; 3District Hospital, Lushnje, Albania;
CORRELATION OF SERIC BIOMARKERS AND CELLULAR ELEMENTS IN SPUTUM AND BLOOD, IN RELATION TO THE GRAVITY OF COPD
Research in relation to the biomarkers to define exacerbation, gravity and it’s progress in COPD has been made and continued to be made. By present literature, it result that biomarkers correlate with clinical gravity, with the time of the recovery period, persistence of symptoms and clinical resolution, with exacerbation frequency. Aim: The study has as an aim, the evaluation of the correlation of seric biomarkers and cellular elements in sputum, and blood in relation to the gravity of COPD. Method: The abstract is an observing prospective study conducted on the Regional Hospital “Fier”. In the study, patients presented with exacerbated COPD of stages III and IV were considered. Based on a protocol, in patients with COPD exacerbations,anamnestic data as well as data from clinical and laboratoric examinations was collected. It has been defined in the time of introduction for the reason of COPD exacerbations and after 21 days, CRP, IL6, PARC/CCL18, cellular content of sputum and blood. The statistical analysis was conducted through SPSS (Statistical Package for Social Sciences) 20.0 and Medstat. Values of p ≤0.05 were considered significant. Results: In the patient with COPD exacerbations of stages III and IV, significant changes of cellular elements in blood and sputum were observed. In relation to the values of the original CRP in normal boundaries there is no case in the D4 category and value higher than the level from 40 to 200 mg/l are in relation to categories D3 and D4. In the examination of IL6 in exacerbation,it can be observed that cases with a level >7 pg/ml are grouped in categories D3 and D4; PARC in values >30ng/ml are 91.1% of cases, whereas in values >60 ng/ml are in 66.1% of cases.The greatest number of cases PARC in the values >30ng/ml, as well as for values >ng/ml, are in categories D3 and D4.According to the data of the correlations analysis, it results that original CRP correlated in a significant manner with COPD stage (p=0.005); IL6 (p=0.038). PARC (p=0.054). Conclusions: It results that there are significant changes in stages III and IV in relation to the stage of inflammation based on cellular structure in sputum, number and cellular elements of blood and the levels of CRP, IL6 and PARC/CCL18 in blood.